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Infection with the human immunodeficiency virus (HIV) results in alterations in immune cells such as an increase or decrease of cytokine
secretion and immunodeficiency. HIV causes a state of chronic cellular activation that can induce apoptosis in lymphocyte T-helpers, making the
patient susceptive to opportunistic infections. The biochemical mechanisms involved in this immune response to HIV have been researched. Here,
we have shown for the first time that ATP and ADP hydrolysis are essential for the immune response to HIV. Our results clearly indicate an
increase of NTPDase-1 (EC 3.6.1.5) activity in lymphocytes of HIV-positive patients, confirmed by an enhanced CD39 expression on its surface.
These results suggest that NTPDase-1 may be important to keep an adequate balance between the generation and consumption of ATP and to
preserve cellular integrity and immune response to the HIV infection.
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NTPDase-1 (EC 3.6.1.5) is an enzyme that hydrolyzes
extracellular nucleoside tri- and/or diphosphates forming AMP
that can serve as a substrate for an ecto-5V-nucleotidase (EC
3.1.3.5) with release of adenosine a modulator of vascular tone
and inhibitor of platelet aggregation. This class of enzyme has
been described in mammals [1–4] and NTPDase-1 was
identified as a lymphoid cell antigen CD39 protein [5].
Extracellular nucleotides and nucleosides play an important
role in signaling cascades that include several cellular events
such as neurotransmission, platelet aggregation and inflamma-
tory and immune responses [6]. Nucleotides, after exerting
their function through purinoreceptors, are hydrolyzed in the
extracellular medium [7]. Thus, the duration and magnitude of0167-4889/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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ectoenzymes such as NTPDase-1 [8].
NTPDase-1 (CD39) activity occurs in lymphocytes from
human peripheral blood, thymocytes and mouse spleen
lymphocytes and its activity is higher in human B cells
than in T cells [9]. The increased expression of CD39 is
associated with an enhancement in ATPase and ADPase
activities in these cells besides demonstrating a state of
cellular activation in lymphocytes [10]. The fact that CD39
is expressed only on subsets of activated T lymphocytes
suggests a possible role of CD39 in cell–cell adhesion
and thus CD39+ cells may facilitate more efficiently the
interaction among lymphocytes with other cells of the
immune system [11].
NTPDase-1 activity was recently characterized by Leal et al.
[4] in human peripheral lymphocytes and its presence was
confirmed by a low density of fluorescence detected by
cytometric analysis of CD39. The enzyme characterized
showed cation dependency, optimum activity in pH 8.0,1746 (2005) 129 – 134
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associations were eliminated by the use of selective inhibitors.
However, its possible association with immune diseases has
not yet been evaluated. Here, for the first time, we have
investigated the association of NTPDase activity with the
expression of CD39 in the lymphocytes of HIV-patients. Most
importantly, here we have shown that these patients present an
increase of NTPDase activity followed by an enhanced CD39
expression.
2. Materials and methods
2.1. Chemicals
Nucleotides and Trizma base were purchased from Sigma (St. Louis, MO,
USA). Ficoll-Hypaque (Lymphoprepi) was purchased from Nycomed Pharma
(Oslo, Norway). Antibodies for flow cytometry analysis (R-Phycoerythrin (R-
PE)-conjugated mouse anti-human monoclonal antibody against CD39,
fluorescein isothiocyanate (FITC)-conjugated mouse anti-human monoclonal
antibody against CD25, peridinin chlorophyll protein (PerCP)-conjugated
mouse anti-human monoclonal antibody against CD45 and fluorescein
isothiocyanate (FITC)-conjugated mouse anti-human monoclonal antibody
against CD45) were purchased from BD PharMingen Technical Data Sheet
(San Jose, CA, USA). All other reagents used in the experiments were of
analytical grade and of the highest purity.
2.2. Patients
The sample consisted of 50 healthy volunteers and 50 HIV-positive patients
from the Hospital of the Federal University of Santa Maria (Santa Maria, RS,
Brazil). All subjects gave written informed consent to participate in the study.
The Human Ethics Committee of the Health Science Center from the Federal
University of Santa Maria approved the protocol under the number 13690. The
control group was carefully selected by clinical evaluation consisting on 50
individuals aged 20–40 years, 50% males and 50% females who did not
undergo any pharmacological therapy during the last month. The 50 patients
infected by HIV were individuals aged 25–42 years, 50% males and 50%
females, both being treated and not by antiretroviral treatment.
2.3. Isolation of mononuclear cells from human blood
Mononuclear leukocytes were isolated from human blood collected with
EDTA and separated on Ficoll –Hypaque density gradients as described by
Bo¨yum [12].
2.4. Enzyme assays
After the isolation of mononuclear cells, the NTPDase activity was
determined as described by Leal et al. [4] where the reaction medium contained
0.5 mM CaCl2, 120 mM NaCl, 5 mM KCl, 60 mM glucose, and 50 mM Tris–
HCl buffer, pH 8.0, at a final volume of 200 AL, and inhibitors of other
ATPases was added to confirm NTPDase activity. Twenty microliters of intact
mononuclear cells suspended on a saline solution were added to the reaction
medium (2–4 Ag protein) and preincubated for 10 min at 37 -C. The reaction
was started by the addition of substrate (ATP or ADP) at a final concentration
of 2 mM and stopped with 200 AL 10% trichloracetic acid (TCA) to provide a
final concentration of 5%. The enzyme incubation times and protein
concentrations were chosen in order to ensure the linearity of the reactions.
The samples were chilled on ice for 10 min before assaying for the release of
inorganic phosphate (Pi) as described for Chan et al. [13], using malachite
green as a colorimetric reagent and KH2PO4 as standard. Controls with the
addition of enzyme preparation after mixing TCAwere used to correct for non-
enzymatic hydrolysis of substrate. All samples were run in duplicate or
triplicate and the specific activity is reported as nmol Pi released/min/mg
protein.2.5. Protein determination
Protein was measured by the Coomassie Blue Method using bovine serum
albumin as standard as described for Bradford [14].
2.6. Flow cytometry analysis for CD39 and CD25
Peripheral blood cells were incubated with anti-CD39, anti-CD25 and anti-
CD45 (20 AL/106 cells) for 25 min, lysed with reagent FACS (Fluorescence
Activated Cell Sorter) lysis and incubated again for 15 min in the dark. Cells
were washed twice in PBS buffer (pH 7.4) containing 0.02% (w/v) sodium
azide and 0.2% (w/v) BSA. The cells were then resuspended in PBS buffer (pH
7.4) and immediately analyzed by FACScalibur flow cytometer using Cellquest
software (Becton Dickinson, San Jose, CA, USA), without fixation.
2.7. Flow cytometry analysis for CD3, CD4, CD8 and CD4/CD8 ratio
Fifty microliters of peripheral blood cells (with K3EDTA as anticoagulant)
of HIV-positive patients and controls were incubated with 20 AL of BD
TriTESTi for 15 min in tubs with TruCOUNTi controls (Becton Dickinson).
The red cells were lysed with 450 AL of BD FACSLysingi solution and the
sample incubated again for 15 min in the dark. After incubation, the tub was
immediately analyzed by FACScaliburi flow cytometer using MultiSETi
software (Becton Dickinson, San Jose, CA, USA), without fixation.
2.8. Viral load determination
The viral load was performed using the VERSANTR HIV-1 RNA 3.0 assay
(Bayer Corporation, Berkelley, CA, USA), a signal amplification nucleic acid
probe assay for the direct quantification of human immunodeficiency virus type
1 (HIV-1) RNA in plasma, using the BayerR system 340 b-DNA Analyzer. 1
mL of plasma with K3EDTA as anticoagulant was used and the minimal limit
detection was 50 copies/mL [15].
2.9. Hematological parameters determination
Quantitative determinations of leucocytes were performed by hematology
analyzer Coulter STKS (Diamond Diagnostics, Holliston, MA, USA) in
peripheral blood. The parameters analyzed were the total number of leucocytes
and the absolute count of lymphocytes as for the control group as the HIV-
positive group.
2.10. Statistical analysis
Data were analyzed by the non-parametric U test (Mann–Whitney test),
considering a level of significance of 5% to determine the differences between
the study group and controls.
3. Results
3.1. Hematological parameters and viral load
Other cellular markers, besides CD39, were determined in
the peripheral blood by flow cytometry, such as a count of
CD4+, CD8+ and CD3+ cells in the control group and the HIV-
positive group. Moreover, it was verified the absolute number
of lymphocytes and total leukocytes in the human peripheral
blood in both groups. In the HIV-positive patients group, the
quantification of viral load by HIV-1 was performed. The
results showed comparing HIV group with controls, an
increase of CD8+ cells (948T54 and 615T54 cells/AL), a
decrease of CD4+ cells (418T39 and 1091T136 cells/AL) and
CD3+ cells (1434T82 and 1794T157 cells/AL) together to
Fig. 1. Box-whisker-plot of NTPDase activity in lymphocytes from healthy
control individuals and HIV-positive patients. ATP (1A) and ADP (1B) were
used as substrate (see Materials and methods). Data represent the mean T
standard error of 50 individuals. Data were analyzed statistically by Mann–
Whitney U test. ***Significant difference from control activity ( P <0.0001).
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absolute count of leukocytes (5954T284 and 7796T296
cells/AL) and lymphocytes (1844T86 and 2290T84 cells/AL).
Results are expressed as the meanTSE (n T50 for each group).
These data are according to immune response to HIV infection
and have been established by many laboratories. The statistical
analysis comparing CD39 expression and NTPDase-1 activity
with CD4, CD8 and CD3 expression, leukocytes and lympho-
cytes number and viral load did not show a significant
correlation between these variables. A tendency to increase
CD39 expression together with CD8 enhancement was
observed and the same behavior was observed for NTPDase-
1 activity (data not shown). The viral load was determined to
confirm the infection in HIV group, showing as result a mean
of 9552T3248 copies/mL (S.E.M.; n =50).
3.2. NTPDase activity
Lymphocytes from HIV-infected patients had a significant
increase of about 40% in the specific activity of ATP and ADP
hydrolysis conforming Mann–Whitney U test (P <0.0001)
when compared to controls (Fig. 1).
3.3. Cytometric analysis of the CD39 and CD25 expression
By statistical analysis the difference was significant
(P <0.0001) between the control group and the HIV-positive
group according to the Mann–Whitney U test, when observed
the percentage of CD39-positive cells. In line with this, the
flow cytometry analysis indicated that the percentage of CD39-
positive lymphocytes in HIV-patients was higher than in
controls (8.04T0.42/5.25T0.17) (Fig. 2). The research of
positive cells for CD25 indicated higher percentages in HIV
group when comparing with controls (3.80 T0.58 and
2.32T0.56, respectively; P <0.05) and the difference between
the groups in relation to CD39+/CD25+ cells (0.85T0.17 and
0.51T0.17, respectively) it was not significant. Fig. 3 illustrates
histograms of the two groups, obtained by flow cytometry.
4. Discussion
This study evaluated NTPDase-1 activity and the percentage
of lymphocytes that express CD39 on their surface in HIV-
infected patients. It is known that CD39 is expressed in
activated lymphocytes and presents NTPDase activity [5,16].
Our aim was to verify its expression and activity in
lymphocytes of HIV-positive patients, where T cells show an
increased turnover, demonstrating a chronic activation state
[17]. The activation of these cells is ATP-dependent as an
energy source, which is catered by mitochondria through the
electron transport chain and oxidative phosphorylation [18].
It was observed that ATP suppress the proliferation of
peripheral lymphocytes due to adenosine production [19] and
incites the DNA synthesis in lymphoid cells of timo, spleen,
lymph nods and peripheral blood [20]. Lymphocytes express
P2Z receptors, which make with that ATP and other nucleo-
tides can induce alterations in intracellular calcium store. Thebind of ATP to P2X7 receptor forms a transmembrane pore,
which modifies the permeability to mono and divalents ions
and increases the intracellular calcium such as P2Z receptor
[21]. Moreover, to make believe that P2X receptor role in
lymphocytes proliferation control is more complex than only
the effectors actions that take to cellular died [22].
CD39 was identify as a lymphoid activation marker
expressed in B lymphocytes, cytotoxic T lymphocytes, NK
cells and endothelial cells, been too recognized in platelets and
megakaryocytes [11,23–25]. It is able to do signs that increase
cell–cell interaction [26,27]. NTPDase1 executes important
role at control of lymphocytes function [28], including antigen
recognition and/or activation of effectors activities of cytotoxic
T cells.
Ecto-ATPase activity expression in T cells, but not in naive
T cells, suggests that its expression is activated by antigen
recognition, showing its involvement in activation regulation
of T cells or effectors functions. The adhesion of T cells to
antigen introduced by APC (antigen presentation cell) is
sufficient to start the T cell activation. CD39 enzymatic
activity (NTPDase) may be responsible for the hydrolysis of
Fig. 2. Box-whisker-plot of CD39 expression on lymphocytes from healthy
control individuals and HIV-positive patients. The analysis was done by flow
cytometry (see Materials and methods). Data represent the meanT standard
error of 50 individuals. Data were analyzed statistically by Mann–Whitney U
test. ***Significant difference from control activity ( P <0.0001).
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cytokine secretion, essential for an immune response to viral
diseases [29]. Its enzymatic action involves the extracellular
ATP hydrolysis process and it was observed that the depletion
of this nucleotide inhibits the type Th1 cytokine secretion. The
main Th1 cytokine is the interferon-g that, once liberated,
activates other subsets of lymphocytes such as TCD8 cells and
B cells or macrophages. Th1-cytokine secretion (IFN-g e
TNF-a) is a form of cellular response maintenance, through an
inflammatory process, activating granulocytes and macro-
phages, besides TCD8 and B lymphocytes, being that theseFig. 3. Histograms of two-color analysis of CD39 and CD25 on lymphocytes illus
results of flow cytometry using R-Phycoerythrin (R-PE)-conjugated mouse anti-h
conjugated mouse anti-human monoclonal antibody against CD25, peridinin chlo
against CD45 and fluorescein isothiocyanate (FITC)-conjugated mouse anti-human m
shown.go on to produce opsonizant antibodies to help the phagocyte
actions.
TCD8 lymphocytes are the main cells able to respond to the
presence of virus, as well as NK cells, and their interaction with
extracellular ATP seems to be essential to raise the degranu-
lation of these cells and their cytotoxic effect [30]. The
degranulation of these cells enables the release of ATP in the
extracellular medium. Besides that, there is a release of perforin
and granzyme that induces the apoptosis and consequently
lyses cells with more ATP release in the medium [31]. ATP
may be toxic to cells by activating P2X7 purinoreceptors, also
causing a lysis of the target cell by increasing of calcium influx
and caspase activation [22]. NTPDase hydrolysis ability is
related to essential events in lymphocyte activation in immune
responses and the main role does not seem to be that of
providing nucleotides to purine salvation pathway [8,29].
In the HIV infection, the immune response suffers severe
disorders such as CD4 cell depletion, as a consequence of an
apoptotic process triggered by chronic cell activation. TCD4
lymphocytes of its chronic activation state express Fas and
FasL (Fas ligand), leading to the activation of caspase-8 and
causing apoptosis with subsequent massive ATP release in the
extracellular medium. CD4 lymphocyte depletion makes the
organism immunodeficient, as it is more apt to opportunist
infections. Extracellular ATP is also able to induce cell
destruction through the P2X7 receptor [22] and thus it would
be appropriate that cells use mechanisms to protect themselves
from these effects. In that case, the increase of NTPDase
activity enhances ATP hydrolysis, saving cells from apoptotic
effects. Furthermore, TCD8 cells that are responsible for
defense against virus can be exhausted by continual activationtrating a normal subject (3A) and a HIV-positive patient (3B). The histogram
uman monoclonal antibody against CD39, fluorescein isothiocyanate (FITC)-
rophyll protein (PerCP)-conjugated mouse anti-human monoclonal antibody
onoclonal antibody against CD45. Percentages of cells present in quadrants are
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ATP hydrolysis from NTPDase is very important, as it
inactivates both the ATP released by the cytotoxic lymphocytes
and that which is released by the destroyed cells (cells lysed by
cytotoxic lymphocytes), which could be a compensatory
response. Our results show that HIV-positive patients have an
NTPDase activity increased with an higher number of CD39-
positive lymphocytes, that is consistent with the cellular
activation. The same can be confirmed by higher CD25
expression, other activation marker (IL-2 receptor).
ATP generation and consumption are important to maintain
its concentration in narrow ranges, controlled in part by
NTPDases. It has already been related that lymphoid cells
possess two enzymes that could produce ATP from the AMP
released in the NTPDase hydrolysis. These enzymes could be
adenylate kinase (EC 2.7.4.3) and ecto-NDP kinase (EC
2.7.4.6) that may restore the ATP pool in the extracellular
medium [8]. This restoration may be enhanced by a low 5V-
nucleotidase activity in human lymphocytes. Peripheral lym-
phocytes seem to have low 5V-nucleotidase activity and
according to the literature, patients with AIDS present a
decrease in this activity compared to healthy subjects, which
could indicate cellular immaturity, as well [32]. What then
would be the destination of the ATP formed? We can suggest
that the AMP formed by NTPDase could be rephosphorylated
by adenylate kinase and NDP kinase, restoring the extracellular
ATP pool. In this case, there could be a constant balance
between ATP that must be hydrolyzed to avoid cellular
apoptosis and the ATP that must be formed, activating
important immune functions. We suggest that NTPDase
participates in the maintenance of this balance. Furthermore,
we can speculate that 5V-nucleotidase activity is low, producing
low adenosine levels, which could be beneficial to the cell. It is
known that adenosine could incite apoptosis, contributing to
the increase of the immunodeficiency state [33]. Adenosine
would have various undesirable actions in this type of infection
such as a decrease of interleukin-12, an increase of interleukin-
10 and an inversion of the Th1 cellular response to the Th2
humoral response, contributing to the pathogenesis of the
infection [29]. Besides, adenosine has anti-inflammatory and
lymphotoxic effects, decreasing Class II MHC expression in
macrophages and dendritic cells and lowering leukocyte
adhesion [34].
In this scenario, our results suggest that extracellular
nucleotides and their metabolism may be involved in the
immune response to the HIV infection. Our data propose that
during chronic HIV infection there is an increase of ATP
released in the extracellular medium by apoptotic process and
NTPDase-1 hydrolysis of these nucleotides become important.
This hydrolysis could decrease the levels of ATP and its toxic
effects on the cells and save them from nucleotide cytolytic
events. In an injured immune system, it is necessary to save
cells that are essential to response against viral infection and in
this case, NTPDase-1 performs this role, maintaining the ATP
balance. Thus, not only are low ATP concentrations important
to maintain the immune functions, but also toxic ATP
concentrations are avoided. These findings may help tounderstand the mechanisms involved in immune response
against HIV-1 and perhaps NTPDase-1 or CD39 expression
may become useful as a prognostic marker of the HIV
infection.
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